Putnam Investments LLC Orchard Therapeutics PLC Transaction History

Putnam Investments LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$10.15 - $15.58 $10.1 Million - $15.5 Million	-994,892 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$11.88 - $16.72 $1.92 Million - $2.7 Million	-161,261 Reduced 13.95%	994,892 $11.8 Million
Q2 2019 Aug 14, 2019	BUY	$13.2 - $20.63 $10.2 Million - $16 Million	774,853 Added 203.21%	1,156,153 $16.2 Million
Q1 2019 May 15, 2019	BUY	$12.01 - $19.49 $4.58 Million - $7.43 Million	381,300 New	381,300 $6.82 Million

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Putnam Investments LLC with notifications on news.